|Articles|January 1, 2014
- BioPharm International-01-01-2014
- Volume 27
- Issue 1
BioPharm International, January 2014 Issue (PDF)
Click the title above to open the BioPharm International January 2014 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 12 years ago
Best Practices in Adopting Single-Use Systemsabout 12 years ago
Drugs, At What Cost?about 12 years ago
2014 Manufacturing Trends and Outlookabout 12 years ago
Early Communication with Regulators is Essential for SMEsabout 12 years ago
Downstream Purification and Formulation of Fab Antibody Fragmentsabout 12 years ago
Life-Sciences IPOs Take a Breatherabout 12 years ago
Innovation and Market Growth in Brazilabout 12 years ago
Progress in the Prediction of Protein Aggregationabout 12 years ago
Metrics Sought to Ensure Drug QualityNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
2
WHO Finalizes United States’ Withdrawal from Organization: Report
3
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
4
Green Chemistry’s Role in Advancing US Chemical Innovation
5
